Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study

Fig. 2

Proportion of initial fluoroquinolone dispensations for acute bacterial sinusitis between 2005 and 2015 in Canadian provinces*. *Data are presented as percentage of fluoroquinolone dispensations by province for years 2005, 2010 and 2015, and overall fluoroquinolone use is represented as the mean of all data aggregated for years where data is available in at least two provinces. Data not available for AB (2005–2008), MB (2015) and SK (2005–2007). AB Alberta, BC British Columbia, MB Manitoba, NS Nova Scotia, ON Ontario, UTI urinary tract infection, SK Saskatchewan

Back to article page